Functional Whole Genome Screen of Nutrient-Starved Mycobacterium tuberculosis Identifies Genes Involved in Rifampin Tolerance
Author(s)
Matern, William M.; Harris, Harley T.; Danchik, Carina; McDonald, Marissa; Patel, Gopi; Srivastava, Aashish; Ioerger, Thomas R.; Bader, Joel S.; Karakousis, Petros C.; ... Show more Show less
Downloadmicroorganisms-11-02269.pdf (1.312Mb)
Publisher with Creative Commons License
Publisher with Creative Commons License
Creative Commons Attribution
Terms of use
Metadata
Show full item recordAbstract
<i>Mycobacterium tuberculosis</i> (<i>Mtb</i>), the causative agent of tuberculosis (TB), poses a global health challenge and is responsible for over a million deaths each year. Current treatment is lengthy and complex, and new, abbreviated regimens are urgently needed. <i>Mtb</i> adapts to nutrient starvation, a condition experienced during host infection, by shifting its metabolism and becoming tolerant to the killing activity of bactericidal antibiotics. An improved understanding of the mechanisms mediating antibiotic tolerance in <i>Mtb</i> can serve as the basis for developing more effective therapies. We performed a forward genetic screen to identify candidate <i>Mtb</i> genes involved in tolerance to the two key first-line antibiotics, rifampin and isoniazid, under nutrient-rich and nutrient-starved conditions. In nutrient-rich conditions, we found 220 mutants with differential antibiotic susceptibility (218 in the rifampin screen and 2 in the isoniazid screen). Following <i>Mtb</i> adaptation to nutrient starvation, 82 mutants showed differential antibiotic susceptibility (80 in the rifampin screen and 2 in the isoniazid screen). Using targeted mutagenesis, we validated the rifampin-hypersusceptible phenotype under nutrient starvation in <i>Mtb</i> mutants lacking the following genes: <i>ercc3</i>, <i>moeA1</i>, <i>rv0049</i>, and <i>rv2179c</i>. These findings shed light on potential therapeutic targets, which could help shorten the duration and complexity of antitubercular regimens.
Date issued
2023-09-09Department
Massachusetts Institute of Technology. Institute for Medical Engineering & Science; Harvard University--MIT Division of Health Sciences and TechnologyPublisher
Multidisciplinary Digital Publishing Institute
Citation
Microorganisms 11 (9): 2269 (2023)
Version: Final published version